Inability to cooperate with treatment protocol
Inability to comply with protocol-mandated hospitalization and activities restrictions
Inability to comply with requirements for cisplatin administration anti-emetic regimens post-treatment
Inability to comply with visit schedule or other protocol requirements.
Inability to cooperate with treatment protocol
Inability to comply with study requirements
Inability to comply with protocol requirements
Inability to comply with the protocol and/or not willing or not available for followup assessments
Inability to comply with treatment per investigator discretion
Inability to comply with protocol requirements
Inability to comply with treatment per investigator discretion
Inability to comply with protocol requirements
Inability to co-operate with the requirements of the protocol
Inability to comply with protocol requirements
Inability to give informed consent and comply with the protocol.
Inability to cooperate with the requirements of the protocol
Inability to comply with protocol requirements
Inability to comply with protocol requirements
Inability to comply with protocol requirements
Inability to comply with protocol requirements, including pharmacokinetic (PK) studies (phase I only) and genetic studies
Inability to comply with protocol requirements
Inability to practice contraception with condoms as prescribed by the protocol
Inability to comply with protocol requirements
Inability to co-operate with the requirements of the protocol
Inability to comply with study instructions
Inability to comply with protocol
High risk of inability to comply with transplant protocol, or inability to give appropriate informed consent in the estimation of the principal investigator (PI), social work, psychiatry, or the stem cell transplant team
Inability to comply with the treatment protocol or to undergo pre-specified follow-up tests for safety or effectiveness
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with other requirements of the protocol
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Inability to comply with protocol requirements
Inability to comply with IL-2 treatment regimen
Participants with inability to comply with IL-2 treatment regimen
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to co-operate with the requirements of the protocol
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
Inability to comply with protocol requirements
Inability to understand or comply with study protocol
Inability to comply with study requirements
Inability to comply with the protocol activities
inability to comply with the protocol activities
Sufficient mental capacity to comply with the protocol requirements,
Inability to comply with the study protocol.
Inability to comply with requirements of the protocol
Patients with the inability or with foreseeable incapacity, in the opinion of the Investigator, to comply with the protocol requirements.
Likely inability to comply with the protocol or cooperate fully with the investigator and site personnel
Patients with the inability, in the opinion of the Investigator, to comply with the protocol requirements
Inability to comply with protocol and/or not willing or not available for follow-up assessments
Known or suspected inability to comply with the study protocol.
Inability to comply with protocol requirements
Known or suspected inability to fully comply with study protocol.
Known or suspected inability to fully comply with study protocol
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Inability to comply with the pre-op diet
Inability to comply with protocol requirements including refusal to forego pre-procedural opioid use
Inability to comply with study requirement
Inability to comply with IL-2 treatment regimen
Has inability to give informed consent or comply with study requirements
Subjects who the investigator believes can and will comply with the requirements of the protocol.
Subjects who the investigator believes can and will comply with the requirements of the protocol
Inability to comply with protocol and/or not willing or not available for follow-up assessments
Inability to comply with protocol requirements
Inability to comply with the photosensitivity precautions associated with the study
inability to comply with the protocol
Inability to comply with instructions
Foreseen inability to comply with study requirements
Patients who are otherwise felt unable to comply with the protocol, in the opinion of the investigator
Patients unable to comply with instructions for DIBH
Unwilling or unable to provide written informed consent, comply with study requirements, or be available for follow-up assessments
Patients unable to comply with the protocol
The subject or guardian is unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up and research tests.
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up, and research tests.
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, long-term follow-up, and research tests.
Unable to comply with the requirements of the protocol, or unable to provide adequate informed consent in the opinion of the principal investigator
Patients who are not available for follow-up assessments or unable to comply with study requirements
Unable to comply with protocol
Unstable psychiatric disorder that would render the patient unable to comply with study requirements.
Unable to comply with study requirements in the opinion of the Investigator.
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up and research tests
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up, and research tests
Unable to provide informed consent or, in the opinion of the Principal Investigator, comply with the protocol.
Patients who, for medical or other reasons, are unable to comply with the study procedures
Unable to comply with the requirements of the protocol, or unable to provide adequate informed consent in the opinion of the principal investigator
Patients unable to comply with the protocol as judged by the investigator.
Patient unable to consent or comply with study guidelines
Is unable to comply with study requirements
Unable to give informed consent or comply with clinical trial requirements
The patient or parent(s)/guardian(s) is/are unable to comply with the study visit schedule and other protocol requirements, in the opinion of the investigator.
Patients who, in the opinion of the investigator, are unable to comply with the requirements of the study protocol are not eligible
Patients who are not available for follow-up assessments or unable to comply with study requirements
Patient unable to comply with the protocol, in the opinion of the investigator.
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up, and research tests
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up and research tests
Patients unable to comply with the protocol
Unable to comply with treatment with the NovoTTF-100A device
A subject who, in the opinion of the sponsor-investigator will be uncooperative or unable to comply with study procedures
Unable to comply with study requirements in the opinion of the Investigator.
Patient is unable to comply with the requirements of the study.
Patients unable to comply with the protocol
Unable to comply with the protocol for any reason
Any patients who are unable to comply with the study procedures as determined by the study investigators
Unable to comply with protocol and/or not available for follow-up assessments
Has any other condition or prior therapy that in the opinion of the Investigator would make the patient unsuitable for the study and/or unable to comply with requirements for follow-up visits.
Any patient, in the opinion of the investigator, who is unable or unlikely to comply fully with the study requirements or procedures for any reason
Unable to comply with the protocol for any reason
Patient unable to comply with the treatment protocol including appropriate supportive care, follow-up and research tests
Patient or guardian unable to give informed consent or unable to comply with the treatment protocol including appropriate supportive care, follow-up and research tests
A subject who, in the opinion of the sponsor-investigator will be uncooperative or unable to comply with study procedures
If, in the opinion of the Investigator, the patient is deemed unwilling or unable to comply with the requirements of the Study
Individuals who are unable to comply with photosensitivity precautions
Unable to provide informed consent or high risk that patient may not comply with\n             protocol requirements (i.e. due to health and/or participation in other research\n             studies).
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who in the opinion of the investigator are unable to comply with the safety monitoring requirements of the study
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients unwilling to or unable to comply with the protocol or who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Patients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects will be excluded who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patient, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator may not be able to comply with IL-2 or ECP treatment requirements or the safety monitoring requirements of the study, will be excluded from participation
Non-compliance; defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are NOT eligible for either Stratum
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Inability to comply with the safety monitoring requirements of the study, as judged by the investigator
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Research participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Patients, who in the opinion of the investigator and another independent party, may not be able to adhere to the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with all the study requirements
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Non-compliance: subjects who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study will be considered non-compliant
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Non-compliance: if it is the opinion of the investigator that a subject may be unable to comply with the safety monitoring requirements of the study, they will be excluded
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements and/or follow-up studies of this trial
Patients who in the opinion of the investigator may be unable to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Subjects unwilling to or unable to comply with the protocol, or who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Research participants will be excluded, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study are not eligible
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Participants who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study are not eligible
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Non-compliance defined as any subject, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patient, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients who, in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal, should be excluded.
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Patients must be able to comply with the safety monitoring of the study in the opinion of the investigator
Required observations: Subjects who in opinion of investigator may not be able to comply with required safety and monitoring requirements are not eligible
Patients who in the opinion of the investigator may not be able to comply with the safety monitoring requirements of the study
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of medical noncompliance
History of noncompliance to medical regimens
History of noncompliance to medical regimens
A medical history of noncompliance with HAART or medical therapy
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance with medical regimens
History of noncompliance during previous vaccination cycles with study treatment and/or monitoring which is concerning for continued noncompliance
Patient has a history of noncompliance to medical regimens or is unable to grant consent.
History of noncompliance to medical regimens
A medical history of noncompliance with HAART or medical therapy
History of noncompliance to medical regimens
History of noncompliance to medical regimens.
History of noncompliance to medical regimens or unwillingness to comply with the protocol
History of noncompliance to medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens or patients who are considered potentially unreliable not cooperative
History of noncompliance to medical regimens
History of noncompliance to medical regimens or coexisting -
History of noncompliance to medical regimens
History of noncompliance to medical regimens
Patients unwilling or unable to comply with protocol therapy, tests, and visits, or with a history of noncompliance with medical regimens
EXPANSION COHORT ONLY: Patients unwilling or unable to comply with protocol therapy, tests, and visits, or with a history of noncompliance with medical regimens
History of noncompliance to medical regimens
History of noncompliance to medical regimens
A medical history of noncompliance with HAART or medical therapy
History of noncompliance to medical regimens
Patients with a history of noncompliance to medical treatments and/or considered potentially unreliable
A subject with a history or expectation of noncompliance with medications or treatment protocol
History of medical noncompliance
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements.
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unable to render informed consent and to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Are unable or unwilling to follow protocol instructions and requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements or to give informed consent
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements and the light exposure precautions
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to undergo a MRI per requirements in the study protocol
Unwilling or unable to follow protocol requirements
Subject is unwilling or unable to follow the procedures outlined in the protocol.
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unable to understand instruction and to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow the protocol requirements.
Unwilling or unable to follow protocol requirements
Subject is unable or unwilling to follow study requirements, including signed consent or assent
Unwilling or unable to follow protocol requirements
Unable or unwilling to follow protocol requirements
Unable/unwilling to follow protocol requirements
Unwilling or unable to follow protocol requirements
Unwilling or unable to follow protocol requirements
Patients unable or unwilling to abide by the study protocol or cooperate fully with the investigator
Patients must be able to cooperate fully with all planned protocol therapy
The patient has an inability or unwillingness to abide by the study protocol or cooperate fully with the Investigator or designee.
Subject is unable or unwilling to abide by the study protocol or cooperate fully with the Investigator or designee.
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee.
Patients unable or unwilling to abide by the study protocol or cooperate fully with the investigator
Subjects who are unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee are excluded
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patients who are unable or unwilling to abide by the study protocol or to cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unwilling or unable to comply with the protocol or cooperate fully with the investigator and site personnel
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The participant is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Patient is unable or unwilling to abide by the study protocol or cooperate fully with the investigator
The subject is unable or unwilling to abide by the study protocol or cooperate fully with the investigator or designee
Unable or unwilling to abide by the study protocol or cooperate fully with the Investigator or designee.
The subject is able and willing to abide by the study protocol or cooperate fully with the investigator or designee
The patient has an inability or unwillingness to abide by the study protocol or cooperate fully with the investigator or designee.
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements or interfere with interpretation of study results.
Subject has any medical, psychiatric, addictive or other disorder which compromises the ability of the subject to give written informed consent and/or to comply with procedures
Any medical, psychiatric, addictive or other kind of disorder which compromises the ability of the subject to give written informed consent and/or to comply with procedures
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.
Any medical, psychiatric, addictive or other kind of disorder which compromises the ability of the subject to give written informed consent and/or to comply with procedures
Patients with known psychological or sociological conditions, addictive disorders or family problems, which would preclude compliance with the protocol
The investigator should assess the patient to determine if she has any psychiatric or addictive disorder or other condition that, in the opinion of the investigator, would preclude her from meeting the study requirements.
Psychiatric of addictive disorders or other condition that in the opinion of the investigator would preclude the patient from meeting the study requirements
Psychiatric or addictive disorders or other conditions that would preclude the patient from meeting the study requirements
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
Patients with psychiatric or addictive disorders that would preclude obtaining informed consent
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements, or interfere with interpretation of study results.
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements or interfere with interpretation of study results
Current addictive or psychiatric disorder which may preclude protocol adherence
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
Serious psychiatric condition or addictive disorder
Psychiatric or addictive disorders or other conditions or unresolved toxicities of prior therapy greater than grade 2 that, in the opinion of the investigator, would preclude the patient from meeting the study requirements, or interfere with interpretation of study results.
Patients must not have known psychological or sociological conditions, addictive disorders or family problems, which would preclude compliance with the protocol
Diagnosis of psychiatric or addictive disorders that would preclude obtaining informed consent
Patients with psychiatric or addictive disorders or other conditions that, in the opinion of the investigators, would preclude them from meeting the study requirements are not eligible
The investigator should assess the patient to determine if she has any psychiatric or addictive disorder or other condition that, in the opinion of the investigator, would preclude her from meeting the study requirements.
Any medical, psychiatric, addictive or other disorder which compromises the ability of the subject to give written informed consent and/or to comply with procedures.
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements.
The patient has a psychiatric, addictive, neurological or other disorder that compromises the ability to give informed consent or comply with study requirements
Patients must not have known psychological or sociological conditions, addictive disorders or family problems, which would preclude compliance with the protocol
Patients with psychiatric or addictive disorders that, in the opinion of the investigator, would preclude obtaining informed consent
Psychiatric or addictive disorders that would preclude obtaining informed consent
Psychiatric or addictive disorders or other conditions that in the opinion of the investigators would preclude the patient from complying with the study protocol
The patient has psychiatric or addictive disorders that may compromise his/her ability to give informed consent, or to comply with the study procedures.
The patient has psychiatric or addictive disorders that may compromise his/her ability to give informed consent, or to comply with the study procedures.
Patients with psychiatric, addictive, or any disorder that would prevent compliance with protocol requirements
Has been diagnosed with psychotic, addictive, and major cognitive disorders
Patients with psychiatric or addictive disorders that would preclude obtaining informed consent
No psychiatric or addictive disorders or other conditions that would preclude the patient from meeting the study requirements
Psychiatric or addictive disorders that would preclude obtaining informed consent or filling out Breast-Q questionnaires
Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements or interfere with interpretation of study results
Psychiatric or addictive disorders that preclude obtaining informed consent
Psychiatric or addictive disorders that preclude obtaining informed consent
Psychiatric or addictive disorders that impair subject’s voluntary ability to participate in informed consent or protocol procedures
Patients with psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
In the opinion of the Investigator patient is unable or unwilling to comply with the protocol.
Patients unwilling to or unable to comply with the protocol
Patient unable or unwilling to comply with the protocol requirements
Patients who are unwilling to comply with protocol
Patients unwilling to or unable to comply with the protocol
Unwilling or unable to comply with the requirements of the study protocol
Assessed by the investigator to be unable or unwilling to comply with the requirements of the protocol
Patients unwilling or unable to comply with the study protocol.
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients assessed by the investigator to be unable or unwilling to comply with the requirements of the protocol
Patients unwilling or unable to comply with the protocol
Patients who are unwilling or unable to comply with all study requirements
Patients unwilling or unable to comply with the protocol.
Patients unwilling to comply with study protocol
Patient is unwilling or unable to comply with study procedures
Is unwilling or unable to comply with study requirements
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Unwilling or unable to comply with the safety monitoring requirements of this protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients who are unwilling or unable to comply with study and/or follow-up procedures
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients is unwilling or unable to comply with study procedures
Patients unwilling or unable to comply with the protocol
Unwilling or unable to, comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the outlined protocol
Patient unwilling to or unable to comply with the protocol
Assessed by the Investigator to be unable or unwilling to comply with the requirements of the protocol.
Is, in the judgment of the investigator, unable or unwilling to comply with the requirements of the study.
Patients unwilling or unable to comply with the protocol, or provide informed consent.
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol, or provide informed consent
Patients unwilling or unable to comply with the protocol, or provide informed consent
Patients unwilling or unable to comply with the study protocol
Patients unwilling to or unable to comply with the protocol
Subjects unwilling to or unable to comply with the protocol
Subject is unwilling or unable to comply with study procedures
Patients unwilling or unable to comply with this study protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Subject is unwilling or unable to comply with study procedures
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol.
Unwilling to or unable to comply with the protocol
Unwilling or unable to comply with the protocol
Unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Assessed by the investigator to be unable or unwilling to comply with the requirements of the protocol
Patients unwilling to or unable to comply with the protocol
Participants unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling to comply with the protocol
Subjects unwilling to or unable to comply with the protocol procedures as assessed by the Investigator
Subject unwilling or unable to comply with study requirements
Patients unwilling or unable to comply with the protocol
Subject is unwilling or unable to comply with study procedures.
Patient is unwilling or unable to comply with study procedures
Patient is unwilling or unable to comply with study procedures
Patient unable or unwilling to comply with the protocol requirements
Patients unwilling or unable for any reason (personal, medical, or psychiatric) to comply with the protocol
Patients unwilling or unable to comply with the study protocol
Patient unable or unwilling to comply with the protocol.
Patients unwilling or unable to comply with the research protocol
Unable or unwilling to comply with all protocol requirements.
Unwilling to, or unable to, comply with the protocol
Assessed by the investigator to be unable or unwilling to comply with the requirements of the protocol
Patients unwilling or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling to or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Patients who are unwilling or unable to comply with the protocol
Unwilling or unable to comply with the protocol
Anyone who, in the investigator’s discretion, would be unwilling or unable to comply with study procedures
Unwilling or unable to comply with the protocol
Patients unwilling or unable to comply with the protocol
Unable or unwilling to comply with study procedures
Patients unwilling to comply with study requirements
Patients unwilling or unable to comply with the study protocol
Subject is unwilling to comply with the requirements of the protocol
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study; the investigator can consult the study chair or study co-chairs for uncertainty in this regard
Major bowel surgery which in the opinion of the Investigator should exclude the patient
The presence of any of the following criteria will exclude the patient from the study:
Prior radiation therapy that would exclude the use of TMLI
Subject has previously received (presence of any of the following will exclude a subject from enrollment):
Exclude if patient has cirrhosis or is currently being actively treated for hepatitis C
Exclude patients with known Kell antibodies
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study
Prior radiation therapy that would exclude the use of TMLI
Any concurrent or past medical condition that, in the opinion of the investigator, would exclude the subject from participation
Prior radiation therapy that would exclude the use of TMLI
Patients with other significant disease or disorders that, in the investigator's opinion, would exclude the patient from the study
No other illness that in the opinion of the investigator would exclude the subject from participating in the study
The presence of any of the following will exclude a subject from enrollment:
Any medical condition that, in the opinion of the investigator, would exclude the patient from participating in this study and treatment plan.
Patients with other significant diseases or disorders that, in the investigator’s opinion, would exclude them from the study
The presence of any of the following will exclude a subject from enrollment:
The presence of any of the following will exclude a subject from enrollment into the Induction and Maintenance parts of the study (except if specified at study entry only):
The presence of any of the following will exclude a subject from enrollment:
No other illness that in the opinion of the investigator would exclude the subject from participating in the study
The presence of any of the following will exclude a patient from enrollment:
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study.
An untreated tumor growth rate of < 6.1% during the Screening period may exclude some patients.
The presence of any of the following will exclude a subject from enrollment:
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study; the investigator should consult the study chair
Patients with any co-morbidities that should exclude sampling
Other illness that in the opinion of the investigator would exclude the patient from participating in this study
Any other significant acute or chronic diseases that in the investigator's opinion would exclude the subject from the trial
Patients that primary care providers exclude
Exclude any patient who has a history of metastatic cancer
Have initiative and means to be compliant with protocol and within geographical proximity to make required study visits as judged by Investigator
Compliant on combined anti-retrovirals (cART) if HIV infected
Not compliant with anti-retroviral therapy (HIV infected participants)
Any patients who cannot be compliant with the appointments required in this protocol must not be enrolled in this study.
Patient (Pt) may be excluded if, in the opinion of the principal investigator (PI) and investigator team, the pt is not capable of being compliant
Pt may be excluded if, in the opinion of the principal investigator (PI) and investigator team, the pt is not capable of being compliant
Any patient who cannot be compliant with the appointments required in this protocol must not be enrolled in this study
Any patients who cannot be compliant with the appointments required in this protocol must not be enrolled in this study
PART 1 EXCLUSION CRITERIA: Potential subjects and/or parents/guardians who, in the opinion of the investigative team, are likely to be non-compliant with study schedules or procedures
PART 2 GROUP 1 EXCLUSION CRITERIA: Potential subjects and/or parents/guardians who, in the opinion of the investigative team, are likely to be non-compliant with study schedules or procedures
PART 2 GROUP 2A EXCLUSION CRITERIA: Potential subjects and/or parents/guardians who, in the opinion of the investigative team, are likely to be non-compliant with study schedules or procedures
PART 2 GROUP 3 EXCLUSION CRITERIA: Potential subjects and/or parents/guardians who, in the opinion of the investigative team, are likely to be non-compliant with study schedules or procedures
Patient, in the opinion of the investigator, is likely to be poorly compliant
Any patients who cannot be compliant with the appointments required in this protocol must not be enrolled in this study
Non-compliant to medications
Non-compliant to medications
Patient is deemed by the investigator to have the initiative and means to be compliant with the protocol (treatment and follow-up)
All patients must be deemed by investigator to have the initiative and means to be compliant with the study protocol (treatment and follow-up)
Patient (Pt) may be excluded if, in the opinion of the principal investigator (PI) and investigator team, the pt is not capable of being compliant
Patients must be, in the opinion of the Investigator, available and compliant for treatment and follow-up.
Patient, in the opinion of the investigator, is likely to be poorly compliant
Patient has been compliant with therapy per treating physician
Patient may be excluded if, in the opinion of the principal investigator (PI) and investigator team, the patient is not capable of being compliant
Patient is deemed by the investigator to have the initiative and means to be compliant with the protocol (treatment and follow-up)
Donor must demonstrate ability to be compliant with study regimen.
Recipient must demonstrate ability to be compliant with medical regimen.
Patient is deemed by the Investigator to have the initiative and means to be compliant with the protocol (treatment and follow-up)
Non-compliant to medications
Unlikely to be compliant with the study intervention
The patient and/or parents/caregivers are expected by the Investigator to be non-compliant with the study procedures.
Psychosocial issues: no appropriate caregivers identified, or non-compliant to medications
Participant has a known diagnosis of mental incapacitation that may affect their ability to consent and be compliant with the protocol
Patient is judged by the investigator to have the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
Patient is judged by the investigator to have the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
INCLUSION CRITERIA (NEXT 60 PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER): Patient is judged by the investigator to have the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
Patient is judged by the investigator to have the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
has the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
Subject is judged by the investigator to have the initiative and means to be compliant with the protocol and be within geographical proximity to make the required study visits
